<DOC DOCNO="nw/wsj/12/wsj_1242@1242@wsj@nw@en@on">
<TEXT PARTNO="000">
<COREF ID="4" TYPE="IDENT">Bausch -AMP- Lomb Inc.</COREF> said 0 <COREF ID="4" TYPE="IDENT">its</COREF> pharmaceuticals subsidiary <COREF ID="7" TYPE="IDENT">agreed</COREF> *PRO*-1 to supply <COREF ID="8" TYPE="IDENT">collagen corneal shields for animal eye surgery</COREF> to <COREF ID="5" TYPE="IDENT">a unit of <COREF ID="6" TYPE="IDENT">International Minerals -AMP- Chemical Corp</COREF></COREF> .
Terms were n't disclosed *-1 .
<COREF ID="7" TYPE="IDENT">The agreement</COREF> marks <COREF ID="4" TYPE="IDENT">Bausch -AMP- Lomb 's</COREF> first venture selling <COREF ID="4" TYPE="IDENT">its</COREF> eye care products for use by veterinarians .
<COREF ID="8" TYPE="IDENT">The collagen corneal shield</COREF> helps speed healing of the cornea after eye surgery .
<COREF ID="8" TYPE="IDENT">The product</COREF> will be distributed *-1 by <COREF ID="5" TYPE="IDENT"><COREF ID="9" TYPE="APPOS" SUBTYPE="HEAD">Pitman - Moore Inc.</COREF> , <COREF ID="9" TYPE="APPOS" SUBTYPE="ATTRIB">a subsidiary of <COREF ID="6" TYPE="IDENT">International Minerals</COREF></COREF></COREF> .
</TEXT>
</DOC>
